O.G. Venture Partners Research
Overview
O.G. Venture Partners (OGVP) is a multi-stage venture capital firm founded in 2017 by Eyal Ofer, backed by a single LP — Eyal Ofer's family office Ofer Global, a multi-generational private portfolio of international businesses spanning shipping, real estate, hospitality, and energy. The firm was formerly known as O.G. Tech Ventures and is officially headquartered in Monaco, with investment teams operating across San Francisco, London, and Tel Aviv. As of mid-2026, OGVP manages approximately $500M in AUM across two funds.
Investment Thesis
O.G. Venture Partners invests with long-term conviction in transformative technology companies, primarily at the early-growth stage. The firm positions itself as founder-friendly and focuses on companies demonstrating strong product-market fit and rapid revenue growth, typically at the Series B or C stage. The single-LP structure allows the team to act with conviction and speed, avoiding the committee dynamics common in institutional multi-LP funds. The firm targets companies across the US, Israel, and Europe with a pronounced emphasis on Israeli-founded or Israeli-connected technology companies.
OGVP describes its approach as investing in "companies that redefine their categories" — backing platforms that use technology to disrupt large incumbent markets. The portfolio spans enterprise software, fintech, healthcare technology, cybersecurity, AI infrastructure, and logistics, reflecting a generalist mandate rather than a narrow sector thesis.
Stage Focus
OGVP primarily targets early-growth rounds, typically Series B and C, though the firm makes selective investments from Series A through Series D and occasionally participates in pre-seed rounds through the network. The Tracxn data shows the firm's entry distribution:
- Series B: 4 investments
- Series C: 3 investments
- Series A: 2 investments
- Series D: 1 investment
- Seed/Pre-Seed: 1 investment
The firm actively leads growth rounds and makes follow-on investments in its strongest portfolio companies through later stages.
Check Size
Typical initial investment: $5M–$15M per round. The firm participates in rounds ranging from $10M to $700M in total size (at the growth stage). OGVP may write larger checks in its highest-conviction follow-on opportunities.
Lead Tendency
OGVP has demonstrated a willingness to lead growth-stage rounds when it has strong conviction. Notable examples include:
- Led IVIX's $60M Series B (August 2025) in AI-powered financial crime detection
- Led BlinkOps' $50M Series B (July 2025) in AI security automation
- Co-led Neko Health's $700M Series C (July 2026) alongside Lightspeed Venture Partners
- Existing investor leading in Peregrine Technologies' $250M Series D (June 2026)
The firm also participates in rounds led by others, particularly when entering existing portfolio company follow-ons.
Fund History
- Fund I: Initially raised at $100M, later expanded to $150M. Deployed across 21 companies with 5 exits.
- Fund II: $400M fund announced September 2022. Currently active.
- Total AUM: ~$500M ($0.5B per firm's own website).
The firm is actively deploying from Fund II, with 6 new investments in 2025 and 3 in the first half of 2026.
Recent Activity
OGVP has been highly active in 2025–2026:
- July 2026: Co-led Neko Health's $700M Series C at an implied multi-billion valuation. David Ofer joined the Board of Directors.
- June 2026: Participated in Peregrine Technologies' $250M Series D at $6.8B valuation.
- June 2026: Joined ZyG's $60M Series A at a $500M valuation (AI e-commerce OS).
- May 2026: Portfolio company Via completed a $493M IPO on the NYSE at a $3.65B valuation — a landmark exit.
- June 2026: Buildots (portfolio) acquired Genda to accelerate construction productivity intelligence.
- February 2026: Participated in Breezy's $10M pre-seed round (AI OS for residential real estate).
- August 2025: Led IVIX's $60M Series B (AI platform for financial crime detection, NYC).
- July 2025: Led BlinkOps' $50M Series B (AI security automation, Israel).
Portfolio Highlights
The OGVP portfolio has produced 6 unicorns, 5 exits (including 2 acquisitions and 1 IPO recently), and multiple companies growing rapidly toward scale:
Active Unicorns:
- Coralogix (coralogix.com): AI-native observability platform unifying real-time security and AI workload insights. Reached unicorn status in 2025.
- Peregrine Technologies (peregrine.io): Full-stack AI platform for public safety and government operations. $6.8B valuation at Series D.
- Neko Health (nekohealth.com): Preventive health scan platform, founded by Spotify's Daniel Ek. $700M Series C, expanding to the US in 2026.
- Lendbuzz (lendbuzz.com): Online auto loan platform. Unicorn, Boston.
- Connecteam (connecteam.com): Employee management platform for deskless workers. Unicorn, NYC.
- Bringg (bringg.com): Cloud and AI-based delivery management platform. Unicorn, Tel Aviv.
- Paxos (paxos.com): Blockchain infrastructure and regulated stablecoin platform. Unicorn, NYC.
Notable Exits:
- Via (ridewithvia.com): Israeli-founded transit software platform. Completed $493M NYSE IPO at $3.65B valuation (May 2026). One of Israel's most notable tech IPOs.
- Oosto: Computer vision company acquired by Metropolis (January 2025).
- SuperPlay: Gaming company acquired by Playtika (September 2024).
- SecDo: Cybersecurity (SIEM/XDR). Acquired by Palo Alto Networks.
- Indegy: Industrial cybersecurity (ICS). Acquired by Tenable.
Team
- David Ofer, Managing Partner (Global): Son of Eyal Ofer, leads the firm globally. Based in London/global. LinkedIn: linkedin.com/in/david-ofer. Has joined Neko Health's Board of Directors (July 2026).
- Roy Oron, Managing Partner (Israel): Leads Israel operations. Former CEO of SOSA (a global innovation center). Actively sources and leads investments in Israeli companies.
- Ziv Kop, Partner: Growth investor based in Israel. Co-manages the Israel office with Roy Oron.
- Josh Ephraim, General Counsel: Joined January 2026. Based in San Francisco. UC Berkeley Haas School of Business. Former attorney at Cooley LLP. Handles legal and investment structuring.
- Jean-Paul Hu, Investor: Based in San Francisco.
- Adi Rotem Mintus, Principal: Based in Tel Aviv. Sources and evaluates Israeli deals.
- Dov Rozenberg, Principal: Based in Israel.
- Eyal Ofer: Founder and sole LP. Active in deal selection — cited in Neko Health Series C announcement.
Geographic Focus
The firm has a strong bias toward Israeli-founded technology companies and US-based growth-stage companies. Investment geography (first-round entries):
- United States: 6 investments (primary market)
- Israel: 4 investments (secondary market, strong cultural connection)
- Sweden: 1 investment (Neko Health)
The team map on the firm's website shows offices in San Francisco, London, and Tel Aviv, reflecting a global but focused geographic mandate. The firm is particularly well-networked in Israeli tech.
Decision Process
OGVP operates as a partnership between two Managing Partners (David Ofer for global/US, Roy Oron for Israel) with supporting partners and principals. The single-LP structure removes traditional LP approval layers and allows faster decision-making. The firm is known for founder-friendly terms and a collaborative approach.
Sector Analysis
The portfolio is broadly diversified across growth-stage technology, with the strongest concentration in:
- Enterprise software and AI infrastructure: Coralogix (observability), Buildots (construction intelligence), Connecteam (HR tech), IVIX (financial crime AI), BlinkOps (security automation)
- Fintech and financial infrastructure: BlueVine (SMB banking), Lendbuzz (auto lending), Paxos (blockchain/stablecoin), IVIX
- Healthcare technology: Neko Health (preventive health scans), Remepy (hybrid pharmaceuticals + digital), Dandy (dental tech)
- Cybersecurity: SecDo (acquired by PANW), Indegy (acquired by Tenable), Peregrine (government AI with security governance)
- Logistics and transportation: Via (transit software, NYSE IPO), Bringg (delivery management)
- Consumer and e-commerce: Elementor (website builder), ZyG (AI e-commerce OS)
Tech theme: AI/ML cuts across the entire portfolio — the firm is increasingly backing AI-native applications across verticals rather than AI as a standalone sector.
Anti-Thesis
No explicit anti-thesis documented, but the portfolio suggests the firm avoids: pure consumer social media, early-stage pre-revenue companies (except selectively), deep hardware/semiconductor plays, and emerging markets outside the US/Israel/Europe triangle.